Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin and Wintergreen Throat Sprays for Common Cold Symptoms
NCT06106880Phase 1Completed
- Sponsor
- Applied Biological Laboratories
- Start
- May 2022
- Primary completion
- Apr 2023
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of aspirin throat spray + placebo in common cold and pharyngitis, sponsored by Applied Biological Laboratories. Started May 2022; status: completed.
02
Drugs
aspirin throat spray + placebo
03
Conditions
common coldpharyngitis
Beyond the preview
Go deeper on NCT06106880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06106880.